|
LINS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.555300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.715090E-03 |
| Normal-vs-Stage2 |
1.194290E-02 |
| Normal-vs-Stage3 |
4.845600E-02 |
| Normal-vs-Stage4 |
5.564000E-02 |
| Stage1-vs-Stage2 |
3.634800E-01 |
| Stage1-vs-Stage3 |
3.647200E-01 |
| Stage1-vs-Stage4 |
5.834000E-01 |
| Stage2-vs-Stage3 |
1.690030E-01 |
| Stage2-vs-Stage4 |
2.439400E-01 |
| Stage3-vs-Stage4 |
8.298600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.382300E-03 |
| Normal-vs-AfricanAmerican |
1.703510E-03 |
| Normal-vs-Asian |
1.541590E-03 |
| Caucasian-vs-AfricanAmerican |
7.537700E-02 |
| Caucasian-vs-Asian |
1.029150E-01 |
| AfricanAmerican-vs-Asian |
4.027000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.463800E-03 |
| Normal-vs-Female |
4.582500E-04 |
| Male-vs-Female |
2.148800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.640800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.207290E-04 |
| Normal-vs-Age(61-80Yrs) |
3.251500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.793400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.099200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.753200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.944400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.627700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.228600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.374200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.96140000000256E-05 |
| Normal-vs-Grade 2 |
8.33390000000156E-05 |
| Normal-vs-Grade 3 |
2.892000E-02 |
| Normal-vs-Grade 4 |
4.251600E-01 |
| Grade 1-vs-Grade 2 |
1.456190E-01 |
| Grade 1-vs-Grade 3 |
1.105620E-02 |
| Grade 1-vs-Grade 4 |
9.120200E-03 |
| Grade 2-vs-Grade 3 |
3.110000E-02 |
| Grade 2-vs-Grade 4 |
2.337500E-02 |
| Grade 3-vs-Grade 4 |
3.597200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.03810000000738E-05 |
| Normal-vs-ccB subtype |
1.098380E-01 |
| ccA subtype-vs-ccB subtype |
1.149940E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.353400E-04 |
| Normal-vs-N1 |
3.415600E-01 |
| N0-vs-N1 |
7.160200E-01 |
|
|
